Abstracts

Genes associated with angiogenesis may be regulated by metabolic radiotherapy on cholangiocarcinoma cells

Background Cholangiocarcinoma (CC) is an aggressive bile duct tumor with a high mortality rate and limited treatment. We evaluated the effect of metabolic radiotherapy w...

06/27/2022

Pancreatic cancer as a systemic disease – real-world data from a Portuguese oncological centre

Background Pancreatic adenocarcinoma account for 90% of pancreatic cancer. Only 20% present with resectable or borderline resectable disease, and one third of these pati...

06/27/2022

Q-TWiST analysis for pembrolizumab plus chemotherapy versus chemotherapy as first-line treatment for patients with advanced esophageal cancer in the KEYNOTE-590 study

Background In the phase 3 KEYNOTE-590 study (NCT03189719), first-line pembrolizumab plus chemotherapy provided statistically significant and clinically meaningful improv...

06/27/2022

The prognostic significance of early expression of epithelial-to-mesenchymal transition markers in resectable pancreatic cancer patients

Background Pancreatic ductal adenocarcinoma cancer (PDAC) is the seventh leading cause of cancer death worldwide, mainly due to late-stage presentation, therapy resistan...

06/27/2022

Maintenance chemotherapy in advanced and metastatic pancreatic cancer, a case series

Background Pancreatic cancer is the 12th most common cancer in the world and is responsible for 7% of all cancer deaths. Limited data exists on the management of patient...

06/27/2022

Policy analysis for gastrointestinal cancer care in MENA region

Background With rapid population growth, population aging and changing lifestyle at MENA Region (Middle East & North Africa countries) number of newly diagnosed (GI)...

A. Abotaleb ;

06/27/2022

Impact of surgical resection for gastrointestinal stromal tumors (GISTs) patients with initially diagnosed synchronous hepatic metastases on long-term survival outcomes

Background The impact of surgical resection on the long-term outcome of GIST patients with initially diagnosed synchronous hepatic metastases in the targeted therapy era...

06/27/2022

A rare subset of well-differentiated gastro-entero-pancreatic neuroendocrine tumors with positive FDG PET/CT: Is it a sign of an aggressive disease?

Background Neuroendocrine tumors (NETs) are relatively rare and heterogeneous, mostly asymptomatic and discovered incidentally. PET-CT is one of the gold diagnostic stan...

06/27/2022

Molecular signature and MMR status of early- and late-onset colorectal cancer among Arabs

Background Early-onset colorectal cancer (EO-CRC) is increasing in alarming pace globally. Ethnical/ racial disparities in the EOCRC clinicopathological and molecular si...

A. Al Zaabi ;

H. Al Adawi ;

M. Al Shaibi ;

A. Al Shihi ;

F. Al Farsi ;

O. Al Alyani ;

A. Al Mirza ;

M. Al Asmi ;

T. Al Barhi ;

S. Elmoety ;

06/27/2022

Chemoimmunotherapy in the context of total neoadjuvant therapy (TNT) in patients with locally advanced rectal cancer

Background Colorectal cancer is the third most common and the fourth most deadly cancer worldwide, with a high mortality rate in advanced-stage disease. Current standard...

06/27/2022